Overview

Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder

Status:
Completed
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Flupentixol melitracen tablets in the treatment of different types of non random emotional disorders
Phase:
Phase 4
Details
Lead Sponsor:
Peking University Third Hospital
Treatments:
Flupenthixol
Flupenthixol decanoate